Phage diabody repertoires for selection of large numbers of bispecific antibody fragments

Nature Biotechnology

Volumn 14, Issue 9, 1996, Pages 1149-1154

  McGuinness, Brian T ^a   Walter, Gerald ^c,d   Fitzgerald, Kevin ^a   Schuler, Paula ^b   Mahoney, Walt ^b   Duncan, Alexander R ^a   Hoogenboom, Hennie R ^c,d  

^a MEDIMMUNE LTD   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Antibody; Bispecific; Diabody; Library; Phage display; Selection

Indexed keywords

EPITOPE;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CROSS LINKING; HYBRIDOMA; MOLECULAR CLONING; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BISPECIFIC; BACTERIOPHAGES; BASE SEQUENCE; BINDING SITES, ANTIBODY; BIOTECHNOLOGY; CLONING, MOLECULAR; DIGOXIGENIN; DNA, RECOMBINANT; EPITOPES; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MICE; OXAZOLONE; POLYMERASE CHAIN REACTION;

EID: 0029757498     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0996-1149     Document Type: Article

References (32)

1. Winter, G. and Milstein, C. 1991. Man-made antibodies. Nature 349:293-299.
2. Holliger, P. and Winter, G. 1993. Engineering bispecific antibodies. Current Opinions in Biotechnol. 4:446-449.
3. Brissinck, J., Demanet, C, Moser, M., Leo, O., and Thielemans, K. 1991. Treatment of mice bearing BCL 1 lymphoma with bispecific antibodies. J. Immunol. 147:4019-4026.
4. Bagshawe, K.D. 1987. Antibody directed enzymes revive anti-cancer prodrugs concept. Br. J. Cancer 56:531-532.
5. 2 antibody for the delivery of saporin in the treatment of lymphoma. J. Immunol. 141:3662-3670.
6. Milstein, C. and Cuello, A.C. 1983. Hybrid hybridomas and their use in immuno-histochemistry. Nature 305:537-540.
7. Karpovsky, B., Titus, J.A., Stephany, D.A., and Segal, D.M. 1984. Production of target-specific effector cells using hetero-crosslinked aggregates containing anti-target cell and anti-Fc-gamma receptor antibodies. J. Exp. Med. 160:1686-1701.
8. Holliger, P., Prospero, T, and Winter, G. 1993. “Diabodies”: small bivalent and bispecific antibody fragments. Proc. Natt Acad. Sci. USA 90:6444-6448.
9. Desplancq, D., King, D.J., Lawson, D.G., and Mountain, A. 1994. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Protein Eng. 7:1027-1033.
10. Whitlow, M., Filpula, D., Rollence, M.L., Feng, S-L, and Wood, J.F. 1994. Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv. Protein Eng. 7:1017-1026.
11. Kostelny, S.A., Cole, M.S., and Tso, J.Y. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148:1547-1553.
12. Pack, P. and Pluckthun, A. 1992. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry 31:1579-1584.
13. Gruber, M., Schodin, B.A., Wilson, E.R., and Kranz, D.M. 1994. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J. Immunol. 152:5368-5374.
14. Mack, M., Riethmuller, G., and Kufer, P. 1995. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. Natl. Acad. Sci. USA 92:7021-7025.
15. McCafferty, J., Griffiths, A.D., Winter, G., and Chiswell, D.J. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554.
16. Hoogenboom, H.R., Griffiths, A.D., Johnson, K.S., Chiswell, D., Hudson, P., and Winter, G. 1991. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19:4133-4137.
17. Winter, G., Griffiths, A.D., Hawkins, R.E., and Hoogenboom, H.R. 1994. Making antibodies by phage display technology. Ann. Rev. Immunol. 12:433-455.
18. George, A.J., Titus, J.A., Jost, C.R., Kurucz, I., Perez, R, Andrew, S.M., et al. 1994. Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. J. Immunol. 152:1802-1811.
19. Sanna, P.P., De Logo, A., Williamson, R.A., Samson, M.E., Altieri, D.C., Bloom, FE., et al. 1995. Rapid assay of phage-derived recombinant human Fabs as bispecific antibodies. Bio/Technology 13:1221-1224.
20. Clackson, T., Hoogenboom, H.R., Griffiths, A.D., and Winter, G. 1991. Making antibody fragments using phage display libraries. Nature 352:624-628.
21. Huston, J.S., Levinson, D., Mudgett-Hunter, M., Tai, M.S., Novotny, J., Margolies, M.N., et al. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:5879-5883.
22. Griffiths, A.D., Williams, S.C., Hartley, O., Tomlinson, I.M., Waterhouse, P., Crosby, W.L., et al. 1994. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBOJ. 13:3245-3260.
23. Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., et al. 1996. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnology 14:309-314.
24. Jönsson, U., Fägerstam, L, Ivarson, B., Lundh, K., Löfas, S., Persson, B., et al. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11:620-627.
25. Marks, J.D., Griffiths, A.D., Malmquist, M., Clackson, T., Bye, J.M., and Winter, G. 1992. By-passing immunization: building high affinity human antibodies by chain shuffling. Bio/Technology 10:779-783.
26. Marks, J.D., Hoogenboom, H.R., Bonnert, TP., McCafferty, J., Griffiths, A.D., and Winter, G. 1991. By-passing immunization: Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581-597.
27. H gene segments rearranged in vitro. J. Mol. Biol. 227:381-388.
28. Perisic, O., Webb, RA., Holliger, P., Winter, G. and Williams, R.L. 1994. Crystal structure of a diabody, a bivalent antibody fragment. Structure 2:1217-1226.
29. McCafferty, J. 1994. Selection and rapid purification of murine antibody fragments that bind a transition-state analogue by phage display. Appl. Biochem. Biotechn. 47:157-173.
30. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1990. Molecular cloning—a laboratory manual. Cold Spring Harbor Laboratory, New York.
31. Skerra, A. and Pluckthun, A. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240:1038-1041.
32. Mishell, B.B. 1979. pp. 102-103 in Selected methods in cellular immunology. Mishell, B.B. and Shiigi, S.M. (eds.). W.H. Freeman and Company, New York.